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Editorial
Type 1 diabetes: a genetic Pandora’s box?
In this issue of the journal, Delli et al. (1) describe
the changing incidence of type 1 diabetes mellitus
(T1DM) in children born in Sweden to immigrant
parents, a topic of considerable scientific interest, since
these changes must reflect environmental, rather than
purely genetic influences. The take home message
of this article (1) is that patients with T1DM born
to immigrants in Sweden, a country that has a
notoriously high incidence of T1DM, more frequently
carry human leukocyte antigen (HLA)-DQ2 genotypes
and possess glutamic acid decarboxylase 65 (GAD65)
autoantibodies when compared to indigenous Swedish
T1DM patients. Although this observation confirms
that the effect of HLA-DQ2 is not neutral as initially
thought (2), these results strongly argue that in the
subset of T1DM patients described, additional genetic
and/or environmental risk factors must contribute to
the progression of overt disease (1). A recent genome-
wide association study (GWAS) and meta-analysis
found over 40 loci that affect risk of T1DM (3). It
is conceivable that several of those 40 loci identified by
GWAS contain genes of possible functional relevance
to the subgroup of T1DM individuals identified by
Delli et al. (1). These loci include the region 1q32.1
which contains the potent immunoregulatory cytokine
genes, IL-10, IL-19 and IL-20.
The interplay between the environment and genetic
disposition is unquestionably complicated. It is
proposed that the incidence of T1DM is increasing,
with the diagnosis occurring more in younger age
children (4). Although it is acknowledged that there
may be an effect due to migration, the earlier age
that children with T1DM are now presenting could
be related to environmental changes (4). Zung et al.
noted that in Jewish Ethiopians who are genetically at
risk and who immigrated from Ethiopia to Israel (an
area with a high incidence of T1DM), had an increased
risk of developing T1DM as they adopted their new
country’s lifestyle (5). This contradicts the study by
Ehehalt et al. which found that Italian immigrant
children had incidence rates of T1DM that were similar
to their home country and not their new country of
residence, therefore reducing the importance of the
environmental influence (6).
The study by Delli et al. (1) expands the findings
of Ehehalt’s study (6) by investigating whether
multigenerational origin influenced children’s risk
of developing T1DM in an area that has a high
incidence of this disease. In particular, parents and
grandparents were identified as either Swedish (all
family members), non-Swedish or of mixed origins
(some family members of Swedish descent). HLA
typing and islet autoantibody testing were then
performed on those younger than 18 years who were
diagnosed with T1DM. At least one of the HLA
genotypes, either DQ2 or DQ8, was found in 80%
of these patients, a frequency significantly higher
than that found in children of Swedish descent. In
85% of the patients, at least one islet autoantibody
was confirmed with almost half having two or more
autoantibodies. Islet autoantibodies tended to be
more frequent in those of Swedish descent, although
not statistically significant. When the investigators
examined if specific HLA markers were associated
with specific autoantibodies, they found that the
HLA-DQ2 haplotype, more frequent in immigrant
parents, was associated with the GAD65 antibody,
whereas the HLA-DQ8 HLA haplotype, more frequent
in those of Swedish descent, was associated with
IA-2 autoantibodies. In those with neither DQ2 or
DQ8, non-Swedish patients had increased levels of
autoantibodies, which led the authors to postulate that
there are other genes leading to autoimmunity (1).
It is suggested that different ethnic groups have
unique genetic predispositions to developing T1DM.
Kawasaki et al. reported on a form of diabetes that they
termed ‘fulminant’ T1DM, a subgroup of T1DM in
Japanese patients, in whom there are no autoantibodies
and who do not possess the known susceptibility HLA
haplotypes (7). This leads us to inquire more about
the patients without autoantibodies in the study by
Delli et al. (1). Were their HLA haplotypes similar
to expectations or did they vary from those usually
associated with T1DM, suggesting that perhaps the risk
of developing diabetes is not always HLA-dependent?
In addition, only three autoantibodies were checked in
this study, so it is possible that those without detected
autoantibodies could still have distinct autoantibodies
that have yet to be identified (8). The origin of the
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non-Swedish patients (immigrants from the Middle
East and North Africa) could also be relevant given
that it is reported that ∼1/2 of African-Americans
with new-onset T1DM are negative for antibodies at
diagnosis (9). Finally, it was unclear how long the
children had lived in Sweden. Is it possible that those
without antibodies had not lived in Sweden a sufficient
amount of time to develop autoimmunity?
In summary, this study contributes important infor-
mation about how immigration may affect a child’s
risk of developing T1DM in an area that has a known
high incidence of this disease. However, more inves-
tigations are needed to determine whether new risk
alleles influence disease susceptibility and pathogenesis
in the ethnic groups with and without evidence for islet
autoimmunity identified by Delli et al. (1).
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